Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 7339 matches for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

The Kenya Medical Research Institute (KEMRI) signs landmark partnership with Wellcome and Oxford

The Kenya Medical Research Institute (KEMRI) has officially entered into a seven-year Memorandum of Understanding (MoU) with Wellcome, a UK-based charitable foundation, and the University of Oxford. The £91 million agreement was signed at the Wellcome headquarters in London, marking a significant boost for medical research and training in Kenya.

Nuffield Department of Medicine researchers appointed co-Associate Directors of Oxford Global Health

Professor Susanna Dunachie and Dr Caesar Atuire of the Centre for Tropical Medicine and Global Health have been appointed as Co-Associate Directors of the Oxford Global Health initiative.

New international guidelines for the treatment of schizophrenia

Researchers from all regions of the UN have developed a set of consensus guidelines for the treatment of schizophrenia.

Study reveals one in ten people feel NHS has caused them harm

One in ten people surveyed reported that the NHS has caused them physical or emotional harm, according to a new study by researchers at Oxford Population Health and the London School of Hygiene & Tropical Medicine (LSHTM). The study is published in BMJ Quality & Safety.

New paper on sleep published in Current Biology by members of the Vyazovskiy Group and colleagues

This study reports novel fundings from a mouse model called rlss (for restless) of deficient synaptic neurotransmission, that results from a mutation in one of the key SNARE proteins VAMP2.

New study finds an epilepsy drug could be effective for people with depression

A recent study has investigated whether ezogabine, an anticonvulsant drug given to people with epilepsy, is affective for people with depression.

Oxford unmasks the fraudsters behind the forgeries for April Fakes Day 2025

Patricia Kingori, Professor of Global Health Ethics at Oxford Population Health’s Ethox Centre, and The Oxford Research Centre in the Humanities (TORCH), kick off April Fakes Day 2025 with a week-long cultural programme of exhibits and events that expose history’s fakers, fraudsters and those who fool.

Translational Health Sciences academics co-authoring crucial sustainable health care book

The climate crisis is reshaping every aspect of our world, including health care. While health systems are designed to protect and improve lives, they also contribute significantly to environmental degradation through greenhouse gas emissions, waste and pollution, and unsustainable supply chains. How can we transform health care to operate within planetary limits while maintaining fairness, equity, and optimal patient outcomes?

Landmark study finds no benefit of routine use of cerebral embolic protection devices on TAVI stroke risk

Researchers say the devices cannot be recommended for routine clinical use in the UK.

£5.5M Research funding to transform bowel cancer care

Cancer Research UK and partners have today committed £5.5m in funding to form a world-leading research team tasked with making personalised medicine a reality for people with bowel cancer. The team will be co-led by Professor Simon Leedham from the Nuffield Department of Medicine at the University of Oxford.

New research uncovers pathways to prevent premature cell death

New research from the Kennedy Institute has revealed how two important proteins, TBK1 and IKKe, play a crucial role in preventing premature cell death, which can lead to serious inflammation in the body. The findings are particularly relevant for people with a mutation in the TBK1 gene who often develop multiorgan inflammation caused by excessive cell death even in the absence of any infection.

Professor Asifa Majid Named 2024 AAAS Fellow

Professor Majid recognised for contributions to the understanding of language, culture, and cognition in the 2024 AAAS honours list

Making medical research work where it matters most: Global team calls for revolution in GP and community health and care trials

An international team, led the Nuffield Department of Primary Care Health Sciences, is calling for a fundamental shift in how we conduct health research to better serve our real-world health and care needs.

Oxford launches first human trial of aerosol vaccine delivery

The University of Oxford in partnership with the Coler Lab at Seattle Children’s Research Institute (SCRI) has begun a new clinical trial called TB045, which aims to test tuberculosis (TB) vaccine safety and the host immune response in a first-in-human aerosol mycobacterial challenge infection model with healthy adult volunteers.

Daily physical activity, even at light intensities, linked to lower cancer risk

A study led by researchers from Oxford Population Health has found that daily physical activity is linked to a lower risk of cancer. The number of steps taken daily may be more important for cancer risk than the intensity of activity.

One-third of antibiotics used in Vietnam are ‘inappropriate’

Ranking 11th globally in antibiotic use, Vietnam faces a serious risk of drug resistance, and could be ‘running out of treatment options due to antibiotic resistance’.

Digital test is a boost to READ-OUT biomarker study into effective ways of spotting dementia sooner

People could get the right help for the diseases that can cause dementia sooner following the announcement today of a £2 million injection of funding from the government to help spot these earlier.

Informing policy on AI in brain science and mental health

Two researchers in the Department of Psychiatry contributed to key government reports on mental health for MPs and other policy makers.

New study reveals details of key immune mechanism

An international collaboration, initiated by the Jackson Group at the MRC Weatherall Institute of Molecular Medicine, has uncovered new information that could help in the development of drugs to block conditions such as autoimmunity and inflammation.

New project tackles the 'undruggable' in acute leukaemia treatment

University of Oxford researcher, Katherine Vallis, has been awarded new funding from the MRC to launch a project on the use of cell-permeant antibodies for the treatment of acute leukaemia. The funding will allow Prof. Vallis and her team to generate in vivo data on the use of cell-penetrating peptides (CPPs) for cancer applications, a crucial step towards clinical translation.

Load More